Medtech

  • EU ends Edwards Lifesciences antitrust probe

    The European Commission has closed an antitrust probe into Edwards Lifesciences after the company withdrew a policy aimed at so-called "copycat devices". The probe dates back to September 2023, when the Commission carried out a surprise inspection at the facility of a maker of cardiac devices. Edwards later confirmed it was the company subject to [...]

  • Orthofuse raises £2.2m for 3D-printed implants

    Orthofuse has raised £2.2m in a seed round to develop 3D-printed implant systems designed to improve safety and efficiency in orthopaedic surgery. The orthopaedic medtech company is developing implants for orthopaedic trauma and spinal degenerative conditions, procedures that can be technically demanding and time-sensitive, particularly when bone quality is poor. Orthofuse said current implant systems [...]

  • Listen: Cutting surgical site infections with advanced wound tech

    In this episode of the Health Tech World Podcast, we sit down with orthopedic surgeon Dr Ravi Bashyal to explore one of the most overlooked drivers of surgical outcomes: wound management. With millions of hip and knee replacements performed each year, surgical site complications remain a costly and potentially devastating risk for patients and health [...]

  • Dutch startup Xyall secures €7.6 million

    Xyall has raised €7.6m to roll out its automated tissue dissection technology for molecular pathology laboratories worldwide. The Eindhoven-based medtech startup, founded in 2018 by Guido du Pree and Hans van Wijngaarden, digitises and automates the tissue dissection workflow used to prepare tumour samples for molecular analysis, a step in cancer diagnostics that is still [...]

  • Neurent Medical raises €62.5m Series C

    Neurent Medical has raised €62.5m (US$74m) in an oversubscribed Series C financing round to support commercial expansion, broaden clinical evidence and advance its product and indication pipeline. The round was led by MVM Partners, with significant participation from Sofinnova Partners, and included continued support from existing investors EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners [...]

  • Argá Medtech reports 94% lesion durability and strong safety profile in PFA trial

    Argá Medtech has announced positive clinical results from the BURST-AF first-in-human trial, demonstrating the safety, effectiveness, and durability of its Coherent Sine-Burst Electroporation (CSE) System for the treatment of paroxysmal and persistent atrial fibrillation (AF). Data presented at AF Symposium 2026 (Boston, February 5–7) showed 94 per cent overall lesion durability, 100 per cent procedural [...]

  • Exact Imaging raises US$10m to expand ExactVu sales

    Exact Imaging has raised US$10m to accelerate global sales of ExactVu, its micro-ultrasound prostate biopsy system. The funds will be used to speed up sales and wider adoption of ExactVu worldwide. ExactVu uses high-resolution micro-ultrasound for urologic imaging. Micro-ultrasound provides higher-resolution images than standard ultrasound, helping clinicians see tissue in greater detail. The [...]

  • Radiology startup Stratus Medical raises US$10m

    Stratus Medical has raised US$10m to complete development of its lower back pain treatment technology for interventional radiology. Founded in 2019 and based in Texas, the company makes tools for interventional radiologists and other providers performing radiofrequency heat lesion procedures for lower back pain. Radiofrequency heat lesion procedures use heat to destroy nerves that are [...]

  • Centre for Sight launches Eye Health MOT for over-40s

    Centre for Sight has launched a new Eye Health MOT service for people aged 40 and over, offering a detailed, consultant-led assessment designed to provide reassurance and detect early signs of eye disease before symptoms appear. The launch comes amid growing public focus on eye health and vision standards for drivers, with many people questioning [...]

  • Medtech acquisitions kick off 2026

    Early 2026 has already seen two medtech acquisitions, both targeting cardiovascular technologies in markets with strong procedural growth. While it is too early to predict overall deal activity for the year, the transactions offer insight into how strategics are approaching portfolio expansion and technology positioning. One deal involves W. L. Gore and Associates, which said [...]